If you treat patients with epilepsy, the POWER2 study may be an opportunity for those seeking a new investigational treatment option. Vormatrigine, the investigational medicine being studied, is designed to target seizures with a novel mechanism of action.
If you're a US healthcare professional and are interested in speaking with a member of the Praxis medical team to hear more about the study, please provide your contact information.
If you treat patients with epilepsy, the POWER2 study may be an opportunity for those seeking a new investigational treatment option. Vormatrigine, the investigational medicine being studied, is designed to target seizures with a novel mechanism of action.
If you're a US healthcare professional and are interested in speaking with a member of the Praxis medical team to hear more about the study, please provide your contact information.